 |
 |

May 12, 1999
JAMA. 1999;281:1765-1766.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.
Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for . . . [Full Text of this Article]
RELATED ARTICLES
Diabetes Care and Patient-Oriented Outcomes
Michael Berger and Ingrid Mühlhauser
JAMA. 1999;281(18):1676-1678.
EXTRACT
| FULL TEXT
First Unaffected Pregnancy Using Preimplantation Genetic Diagnosis for Sickle Cell Anemia
Kangpu Xu, Zhong Ming Shi, Lucinda L. Veeck, Mark R. Hughes, and Zev Rosenwaks
JAMA. 1999;281(18):1701-1706.
ABSTRACT
| FULL TEXT
Depressed Adolescents Grown Up
Myrna M. Weissman, Susan Wolk, Risë B. Goldstein, Donna Moreau, Philip Adams, Steven Greenwald, Claudia M. Klier, Neal D. Ryan, Ronald E. Dahl, and Priya Wickramaratne
JAMA. 1999;281(18):1707-1713.
ABSTRACT
| FULL TEXT
The Definition of Anemia in Older Persons
Gerbrand J. Izaks, Rudi G. J. Westendorp, and Dick L. Knook
JAMA. 1999;281(18):1714-1717.
ABSTRACT
| FULL TEXT
Malondialdehyde-Modified LDL as a Marker of Acute Coronary Syndromes
Paul Holvoet, Désiré Collen, and Frans Van de Werf
JAMA. 1999;281(18):1718-1721.
ABSTRACT
| FULL TEXT
The Safety of Newly Approved Medicines: Do Recent Market Removals Mean There Is a Problem?
Michael A. Friedman, Janet Woodcock, Murray M. Lumpkin, Jeffrey E. Shuren, Arthur E. Hass, and Larry J. Thompson
JAMA. 1999;281(18):1728-1734.
ABSTRACT
| FULL TEXT
Anthrax as a Biological Weapon: Medical and Public Health Management
Thomas V. Inglesby, Donald A. Henderson, John G. Bartlett, Michael S. Ascher, Edward Eitzen, Arthur M. Friedlander, Jerome Hauer, Joseph McDade, Michael T. Osterholm, Tara O'Toole, Gerald Parker, Trish M. Perl, Philip K. Russell, Kevin Tonat, and for the Working Group on Civilian Biodefense
JAMA. 1999;281(18):1735-1745.
ABSTRACT
| FULL TEXT
Advances in Molecular Genetics and Management of Hypertrophic Cardiomyopathy
Lameh Fananapazir
JAMA. 1999;281(18):1746-1752.
EXTRACT
| FULL TEXT
|